BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

83 related articles for article (PubMed ID: 25356805)

  • 1. Comment on 'Reasons for non-uptake and subsequent participation in the NHS bowel cancer screening programme: a qualitative study'.
    Tai CK; Leung P; Poullis A; Curry G
    Br J Cancer; 2015 May; 112(11):1834. PubMed ID: 25356805
    [No Abstract]   [Full Text] [Related]  

  • 2. Reasons for non-uptake and subsequent participation in the NHS Bowel Cancer Screening Programme: a qualitative study.
    Palmer CK; Thomas MC; von Wagner C; Raine R
    Br J Cancer; 2014 Apr; 110(7):1705-11. PubMed ID: 24619071
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prevalence of medical reasons for non-participation in the Scottish breast and bowel cancer screening programmes.
    Mead L; Porteous L; Tait M; Stoker R; Payne S; Calvert C; Maxwell D; Katikireddi SV
    J Med Screen; 2015 Jun; 22(2):106-8. PubMed ID: 25753487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A qualitative investigation of factors influencing participation in bowel screening in New South Wales.
    Dawson G; Crane M; Lyons C; Burnham A; Bowman T; Travaglia J
    Health Promot J Austr; 2016 Apr; 27(1):48-53. PubMed ID: 26859797
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Market segmentation tools provide insights into demographic variations in bowel cancer screening uptake.
    Gavens L; Whiteley L; Belencsak A; Careless J; Devine S; Richmond N; Muirhead A
    J Epidemiol Community Health; 2019 Aug; 73(8):778-785. PubMed ID: 31129565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reminder letters for bowel screening tests improve uptake.
    Torjesen I
    BMJ; 2016 Mar; 352():i1804. PubMed ID: 27030557
    [No Abstract]   [Full Text] [Related]  

  • 7. Influences on uptake of cancer screening in mental health service users: a qualitative study.
    Clifton A; Burgess C; Clement S; Ohlsen R; Ramluggun P; Sturt J; Walters P; Barley EA
    BMC Health Serv Res; 2016 Jul; 16():257. PubMed ID: 27405348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Participation rates for organized colorectal cancer screening programmes: an international comparison.
    Klabunde C; Blom J; Bulliard JL; Garcia M; Hagoel L; Mai V; Patnick J; Rozjabek H; Senore C; Törnberg S
    J Med Screen; 2015 Sep; 22(3):119-26. PubMed ID: 25967088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Exploring the decision to participate in the National Health Service Bowel Cancer Screening Programme.
    Ekberg M; Callender M; Hamer H; Rogers S
    Eur J Cancer Prev; 2014 Sep; 23(5):391-7. PubMed ID: 24418799
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A bowel cancer screening plan at last.
    Frank OR; Stocks NP
    Med J Aust; 2015 Mar; 202(4):180-1. PubMed ID: 25716596
    [No Abstract]   [Full Text] [Related]  

  • 11. Motivators for women to attend cervical screening: the influential role of GPs.
    O'Connor M; Murphy J; Martin C; O'Leary J; Sharp L;
    Fam Pract; 2014 Aug; 31(4):475-82. PubMed ID: 24927724
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Controversies about cervical cancer screening: A qualitative study of Roma women's (non)participation in cervical cancer screening in Romania.
    Andreassen T; Weiderpass E; Nicula F; Suteu O; Itu A; Bumbu M; Tincu A; Ursin G; Moen K
    Soc Sci Med; 2017 Jun; 183():48-55. PubMed ID: 28460211
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Learning disabilities: improved bowel screening.
    Bowler M; Nash P
    Nurs Times; 2015 Dec 2-15; 111(49-50):14-6. PubMed ID: 26841578
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-effectiveness of screening for bowel cancer.
    Bolin TD; Korman MG; Nicholson F; Pezzullo L; Engelman J; Collings K; Creelman DG
    Med J Aust; 2016 Jan; 204(1):11-2. PubMed ID: 26763806
    [No Abstract]   [Full Text] [Related]  

  • 15. Open access follow up for inflammatory bowel disease. Ability of any method of follow up to detect cancer must be stated.
    Coomarasamy A; Van Der Berg D
    BMJ; 2000 Jun; 320(7251):1730; author reply 1730-1. PubMed ID: 10917709
    [No Abstract]   [Full Text] [Related]  

  • 16. Predictors of repeat participation in the NHS bowel cancer screening programme.
    Lo SH; Halloran S; Snowball J; Seaman H; Wardle J; von Wagner C
    Br J Cancer; 2015 Jan; 112(1):199-206. PubMed ID: 25429524
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Why do women refrain from mammography screening?
    Sterlingova T; Lundén M
    Radiography (Lond); 2018 Feb; 24(1):e19-e24. PubMed ID: 29306388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A theoretical framework for measuring knowledge in screening decision aid trials.
    Smith SK; Barratt A; Trevena L; Simpson JM; Jansen J; McCaffery KJ
    Patient Educ Couns; 2012 Nov; 89(2):330-6. PubMed ID: 22871477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Non-participation in breast cancer screening among previous cancer patients.
    Virgilsen LF; Pedersen AF; Andersen B; Vedsted P
    J Cancer Res Clin Oncol; 2018 Oct; 144(10):1959-1966. PubMed ID: 30097713
    [TBL] [Abstract][Full Text] [Related]  

  • 20. General practitioners' perceptions of population based bowel screening and their influence on practice: a qualitative study.
    Dawson G; Crane M; Lyons C; Burnham A; Bowman T; Perez D; Travaglia J
    BMC Fam Pract; 2017 Mar; 18(1):36. PubMed ID: 28298185
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.